Patents by Inventor Alkermes Pharma Ireland Limited

Alkermes Pharma Ireland Limited has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPIOID AGONIST ANTAGONIST COMBINATIONS
    Publication number: 20130281388
    Abstract: The invention relates a composition comprising an opioid agonist and Compound-1:
    Type: Application
    Filed: December 17, 2012
    Publication date: October 24, 2013
    Inventor: Alkermes Pharma Ireland Limited
  • NANOPARTICULATE COMPOSITIONS HAVING LYSOZYME AS A SURFACE STABILIZER
    Publication number: 20130224123
    Abstract: The present invention is directed to nanoparticulate active agent compositions comprising lysozyme as a surface stabilizer. Also encompassed by the invention are pharmaceutical compositions comprising a nanoparticulate active agent composition of the invention and methods of making and using such nanoparticulate and pharmaceutical compositions.
    Type: Application
    Filed: December 4, 2012
    Publication date: August 29, 2013
    Applicant: Alkermes Pharma Ireland Limited
    Inventor: Alkermes Pharma Ireland Limited
  • COMPOSITIONS OF BUPRENORPHINE AND ยต ANTAGONISTS
    Publication number: 20130190342
    Abstract: The invention relates to a composition comprising buprenorphine and a ? opioid receptor antagonist, wherein the composition is characterized by an Agonist Antagonist Activity Index (AAnAI) of between about 0.7 and about 2.
    Type: Application
    Filed: December 14, 2012
    Publication date: July 25, 2013
    Applicant: Alkermes Pharma Ireland Limited
    Inventor: Alkermes Pharma Ireland Limited
  • Prodrugs of Secondary Amine Compounds
    Publication number: 20130184265
    Abstract: The present invention relates to compounds of Formula I:
    Type: Application
    Filed: December 14, 2012
    Publication date: July 18, 2013
    Applicant: Alkermes Pharma Ireland Limited
    Inventor: Alkermes Pharma Ireland Limited
  • POLYMER-BASED SUSTAINED RELEASE DEVICE
    Publication number: 20130130977
    Abstract: This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically active polypeptides. The sustained release compositions of this invention comprise a biocompatible polymer having dispersed therein, a biologically active polypeptide and a sugar.
    Type: Application
    Filed: January 16, 2013
    Publication date: May 23, 2013
    Applicants: Amylin Pharmaceuticals, LLC, Alkermes Pharma Ireland limited
    Inventors: Alkermes Pharma Ireland Limited, Amylin Pharmaceuticals, LLC